Diblasi v. Smith & Nephew, Inc.

CourtDistrict Court, D. Connecticut
DecidedFebruary 17, 2021
Docket3:20-cv-00566
StatusUnknown

This text of Diblasi v. Smith & Nephew, Inc. (Diblasi v. Smith & Nephew, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diblasi v. Smith & Nephew, Inc., (D. Conn. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

FRANK DIBLASI,

Plaintiff, No. 3:20cv566 (MPS)

v.

SMITH & NEPHEW, INC. and HEREAUS, INC., Defendants.

RULING ON MOTION TO DISMISS

Frank DiBlasi brings this product liability action under Conn. Gen. Statutes § 52-572m, et seq. against Smith & Nephew, Inc. alleging that its artificial knee joint was defective, and against Hereaus, Inc., a component supplier. Smith & Nephew moves to dismiss the complaint for failure to state a claim under Fed. R. Civ. R. 12(b)(6).1 (ECF No. 20.) For the reasons that follow, the motion is GRANTED IN PART and DENIED IN PART. I. BACKGROUND The following facts are drawn from DiBlasi's amended complaint, ECF No. 16, and are accepted as true for the purpose of this motion. Smith & Nephew is engaged in the manufacture, sale, and distribution of artificial knee joints used in knee replacement procedures. ECF No. 16 at ¶ 3. Heraeus manufactures the cement used with Smith & Nephew's knee joints. Id. at ¶ 5. In 2014, DiBlasi underwent total knee replacement surgery in which a knee joint manufactured by Smith & Nephew was implanted. Id. at ¶¶ 7 - 8. In 2018, DiBlasi noticed a prominent, firm object under the skin of his right knee causing clicking and pain. Id. at ¶ 11. His surgeon determined that DiBlasi had a "loosening of

1 The Court also considered Smith & Nephew's prior brief, ECF No. 13, which the defendant incorporates by reference, and its supplemental memorandum. ECF No. 21. his patella femoral component." Id. at ¶ 12. DiBlasi subsequently was diagnosed with "right knee prosthetic MRSA infection of the right knee." Id. at ¶ 13. He underwent a total knee excision of the infected implant, irrigation, and debridement, and revision with temporary prosthesis. Id. at ¶ 14. About a month later, he underwent a second total knee replacement, removing the temporary prosthesis. Id. at ¶ 15.

Smith & Nephew advertises that its knee replacement implants last longer than other similar devices. Id. at ¶ 19. Its knee replacement implants are made with oxidized zirconium rather than cobalt or titanium, which are more commonly used in such replacement devices.2 Id. at ¶ 20. The FDA recalled thousands of Smith & Nephew defective knee joints.3 Id. at ¶ 25. After the recall, Smith & Nephew continued to misrepresent the fitness of its knee joints and failed to warn prospective end users. Id. at ¶ 26. II. LEGAL STANDARD In deciding a motion to dismiss under Fed. R. Civ. P. 12(b)(6), the Court must determine whether the plaintiff has alleged “enough facts to state a claim to relief that is plausible on its face.”

Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). “A claim has facial plausibility when the plaintiff pleads factual content that allows the Court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). The Court accepts as true all of the complaint's factual allegations when evaluating a motion to dismiss, id., and “must draw all reasonable inferences in favor of the non-moving party,” Vietnam Ass'n for

2 Smith & Nephew contests this allegation, asserting that "the only oxidized zirconium component implanted in Plaintiff is the femoral component" and the complaint does not allege that that particular component is defective. ECF No. 20 at 3. However, at this stage of proceedings, it is not appropriate to contest the accuracy of the allegations. 3 The complaint provides no details about the recall and does not allege that the particular prosthesis implanted in the plaintiff was recalled. Victims of Agent Orange v. Dow Chem. Co., 517 F.3d 104, 115 (2d Cir. 2008). However, “threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice” to survive a motion to dismiss. Mastafa v. Chevron Corp., 770 F.3d 170, 177 (2d Cir. 2014). III. DISCUSSION

The Connecticut Products Liability Act, Conn. Gen. Stat. § 52-572m, et seq., is the "exclusive remedy for all product liability claims in Connecticut." Greco v. Broan-NuTone LLC, No. 3:17cv953(SRU), 2020 WL 1044002, at *9 (D. Conn. Mar. 4, 2020). “The statute does not abolish common law claims in product liability actions, but instead incorporates them into a single count to simplify pleadings." Collazo v. Nutribullet, 473 F. Supp. 3d 49, 51 (D. Conn. 2020). "[A]ny sub-claim brought under the CPLA, such as negligence, strict liability, or breach of warranty, must sufficiently allege all elements that would be required at common law." Philadelphia Indem. Ins. Co. v. Lennox Indus., Inc., No. 3:18cv217(CSH), 2020 WL 705263, at *3 (D. Conn. Feb. 12, 2020).

A. Strict Liability Smith & Nephew argues that the complaint should be dismissed because DiBlasi fails to allege sufficient factual allegations to support his claim that its product is defective. ECF No. 21 at 2 ("He does not plead any facts.") "To state a claim based on strict liability, a plaintiff must plausibly allege that the product designed, manufactured or sold by the defendant was defective and that the defect proximately caused the plaintiff’s injuries." Philadelphia Indem. Ins. Co., 2020 WL 705263, at *3. “A product may be defective due to a flaw in the manufacturing process, a design defect or because of inadequate warnings or instructions." Id. Product liability claims, "whether alleging a design defect, manufacturing defect or failure to warn defect, are governed by the [following] elements . . . : (1) the defendant was engaged in the business of selling the product; (2) the product was in a defective condition unreasonably dangerous to the consumer or user; (3) the defect caused the injury for which compensation was sought; (4) the defect existed at the time of the sale; and (5) the product was expected to and did reach the consumer without substantial change in condition.”

Bifolck v. Philip Morris, Inc., 324 Conn. 402, 434 (2016). "Even under the liberal pleading standards of Rule 8, a complaint generally must identify a specific problem with the design or manufacturing of the subject products." Philadelphia Indem. Ins. Co. v. Lennox Indus., Inc., No. 3:18cv217(CSH), 2019 WL 1258918, at *4 (D. Conn. Mar. 18, 2019). Design Defect "[A] design defect claim is predicated on a product which is otherwise properly manufactured, but is nonetheless unreasonably dangerous because its attributes can cause an unexpected injury.” Leonard v. Gen. Motors LLC, No. 3:19cv1682(SRU), 2020 WL 7024906, at *13 (D. Conn. Nov. 30, 2020) (citation and internal quotation marks omitted). "A product is

defectively designed if: (1) it failed to perform as safely as an ordinary consumer would expect when used in a reasonably foreseeable manner (the “ordinary consumer expectations” test); or (2) in the case of complex products, the risk of danger inherent in the design of the product outweighs its utility (the “modified consumer expectations” test)." Moss v. Wyeth Inc., 872 F. Supp. 2d 162, 166 (D. Conn. 2012). Smith & Nephew argues that DiBlasi fails to allege a design defect claim under either the consumer expectations test or the risk utility test. ECF No. 21 at 2. Admittedly, DiBlasi's pleading is sparse.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Lamontagne v. EI Du Pont De Nemours and Co.
834 F. Supp. 576 (D. Connecticut, 1993)
Mastafa v. Chevron Corp.
770 F.3d 170 (Second Circuit, 2014)
Gallinari v. Kloth
148 F. Supp. 3d 202 (D. Connecticut, 2015)
Moss v. Wyeth Inc.
872 F. Supp. 2d 162 (D. Connecticut, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Diblasi v. Smith & Nephew, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/diblasi-v-smith-nephew-inc-ctd-2021.